For US Patients Only
Makena is a progestin indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history
Makena should not be used in women with any of the following:
There may be some confusion about the current status of Makena. Makena remains available to patients and prescribers. If you have questions or concerns about receiving your therapy as prescribed, consult your healthcare provider.
If you have questions about the status of your prescription, would like to talk with a Care Manager about participation in our patient support program, or would like more information about the FDA hearing discussing Makena, please call 1-800-847-3418, Monday–Friday from 8:00 AM–8:00 PM ET.